MarketStudyReport.com Adds New Diabetic Retinopathy Market 2017 – 2024 research report providing information and data By Product, By Application, Industry Analysis, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 90 Pages with table and figures in it.
Diabetic Retinopathy Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 6.5% CAGR to 2024.
Increasing geriatric population base coupled with rising incidences of age related macular degeneration (AMD) and diabetes will drive diabetic retinopathy market over the coming years. Technological advancements pertaining to diabetic retinopathy treatment and increasing research activities towards developing innovative products for treating vision loss due to diabetes will fuel market growth.
Numerous efforts made by organizations such as Canadian Diabetes Association to provide guidelines for diabetic retinopathy screening to patients suffering from diabetes will favor industry growth. Diabetic eye screening program, and other awareness campaigns arranged by government to reduce disease prevalence will further propel industry growth.
Request sample Copy of this report: https://www.marketstudyreport.com/request-a-sample/467733/?utm_source=BS24&utm_medium=PSR
Non-proliferative diabetic retinopathy market dominated the market in 2016 and is expected to show considerable growth over the coming years. Rising diabetic population as well as increasing number of people suffering from diabetic retinopathy will drive non-proliferative diabetic retinopathy market.
Laser surgery segment is anticipated to witness significant growth over the forecast period due to rising adoption of lasers in various healthcare settings for treatment of diabetic macular edema (DME). Technological advancements in laser treatment to detect eye diseases pre-occurrence of vision loss will further boost market growth. Growing incidences of advanced proliferative diabetic retinopathy will drive vitrectomy segment over the coming years.
UK diabetic retinopathy market should witness robust growth over the forecast period. High technological adoption coupled with rising number of people suffering from diabetic retinopathy will drive UK diabetic retinopathy market. Government initiatives including programs such as ?Action for Diabetes? undertaken to aware people about diabetic associated blindness will positively impact industry growth.
Growing geriatric population base along with growing prevalence of diabetes will drive Japanese diabetic retinopathy market over the forecast period. Increasing application of vitrectomy for treating diabetic macular edema in the country will further boost market growth.
Some of the industry players operating in global diabetic retinopathy market are Allergan, Novartis, Bayer, Genentech and Regeneron Pharmaceuticals.
The companies operating in diabetic retinopathy market are focusing on developing new innovative products by adopting strategies such as strategic collaborations, partnerships and acquisition. For instance, Novartis acquired Encore Vision in December 2016 to strengthen its ophthalmic product portfolio. At present, several research projects are being conducted to identify exact inhibitor that leads diabetes to vision loss.
More Report At: https://empowerednews.net/author/gminsights/
United States Proliferative Diabetic Retinopathy Market Report 2018
In this report, the United States Proliferative Diabetic Retinopathy market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Market Study Report
The Green Suite #4594,
Dover, DE 19901
US Toll Free: 1-866-764-2150
More Report at: http://reports.algosonline.com/